A Fortune Global 500 pharmaceutical company was seeking to launch a key product in Europe and needed help with portfolio pricing guidance and strategy development from early pipeline to launch and through the product’s entire lifecycle. They turned to Business Talent Group (BTG) to find an independent consultant who could optimize the product launch sequence in Europe as the product had already been launched in the US, and support the international reference pricing analysis.
BTG placed an experienced UK-based market access, pricing, reimbursement, and health economics executive in EMEA with deep expertise in biotech and pharma market research, pricing strategy, and product launches specifically in rare diseases.
The talent assessed pricing business cases and provided recommendations while monitoring price erosion in focus markets, all while bringing relevant skills and expertise to the table to facilitate breakthrough thinking and overall innovation.
